Common Stock, Shares, Issued of Syros Pharmaceuticals, Inc. from 31 Dec 2015 to 30 Sep 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Syros Pharmaceuticals, Inc. quarterly Common Stock, Shares, Issued in shares history and change rate from 31 Dec 2015 to 30 Sep 2024.
  • Syros Pharmaceuticals, Inc. Common Stock, Shares, Issued for the quarter ending 30 Sep 2024 was 26,832,457, a 29% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Change (%)

Syros Pharmaceuticals, Inc. Quarterly Common Stock, Shares, Issued (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2024 26,832,457 +6,112,010 +29% 30 Sep 2024 10-Q 31 Oct 2024 2024 Q3
Q2 2024 26,809,764 +6,101,408 +29% 30 Jun 2024 10-Q 31 Jul 2024 2024 Q2
Q1 2024 26,728,337 +6,319,207 +31% 31 Mar 2024 10-Q 14 May 2024 2024 Q1
Q4 2023 26,448,678 +6,185,562 +31% 31 Dec 2023 10-Q 31 Oct 2024 2024 Q3
Q3 2023 20,720,447 +495,095 +2.4% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 20,708,356 -42,280,664 -67% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 20,409,130 -42,392,166 -68% 31 Mar 2023 10-Q 10 May 2023 2023 Q1
Q4 2022 20,263,116 +14,060,713 +227% 31 Dec 2022 10-K 27 Mar 2024 2023 FY
Q3 2022 20,225,352 -41,717,598 -67% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 62,989,020 +1,068,770 +1.7% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 62,801,296 +951,654 +1.5% 31 Mar 2022 10-Q 16 May 2022 2022 Q1
Q4 2021 6,202,403 -50,020,343 -89% 31 Dec 2021 10-K 02 Mar 2023 2022 FY
Q3 2021 61,942,950 +16,135,072 +35% 30 Sep 2021 10-Q 05 Nov 2021 2021 Q3
Q2 2021 61,920,250 +16,161,369 +35% 30 Jun 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 61,849,642 +16,158,924 +35% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 56,222,746 +12,854,945 +30% 31 Dec 2020 10-K 15 Mar 2022 2021 FY
Q3 2020 45,807,878 +3,366,651 +7.9% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 45,758,881 +3,323,384 +7.8% 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 45,690,718 +11,923,777 +35% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 43,367,801 +9,601,937 +28% 31 Dec 2019 10-K 04 Mar 2021 2020 FY
Q3 2019 42,441,227 +8,786,742 +26% 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 42,435,497 +8,814,442 +26% 30 Jun 2019 10-Q 01 Aug 2019 2019 Q2
Q1 2019 33,766,941 +1,530,514 +4.7% 31 Mar 2019 10-Q 01 May 2019 2019 Q1
Q4 2018 33,765,864 +7,342,489 +28% 31 Dec 2018 10-K 05 Mar 2020 2019 FY
Q3 2018 33,654,485 +7,362,034 +28% 30 Sep 2018 10-Q 01 Nov 2018 2018 Q3
Q2 2018 33,621,055 +7,389,352 +28% 30 Jun 2018 10-Q 07 Aug 2018 2018 Q2
Q1 2018 32,236,427 +8,803,699 +38% 31 Mar 2018 10-Q 10 May 2018 2018 Q1
Q4 2017 26,423,375 +3,042,487 +13% 31 Dec 2017 10-K 07 Mar 2019 2018 FY
Q3 2017 26,292,451 +2,922,788 +13% 30 Sep 2017 10-Q 08 Nov 2017 2017 Q3
Q2 2017 26,231,703 +23,547,015 +877% 30 Jun 2017 10-Q 09 Aug 2017 2017 Q2
Q1 2017 23,432,728 31 Mar 2017 10-Q 15 May 2017 2017 Q1
Q4 2016 23,380,888 +21,017,870 +889% 31 Dec 2016 10-K 12 Mar 2018 2017 FY
Q3 2016 23,369,663 30 Sep 2016 10-Q 14 Nov 2016 2016 Q3
Q2 2016 2,684,688 30 Jun 2016 10-Q 15 Aug 2016 2016 Q2
Q4 2015 2,363,018 31 Dec 2015 10-K 20 Mar 2017 2016 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.